We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.49B
Cap. Flow %
8.21%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.56%
2 Technology 14.21%
3 Consumer Discretionary 12.36%
4 Industrials 10.91%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBTM
1651
JBT Marel
JBTM
$6.35B
-66,024
Closed -$6.67M
VSA
1652
VisionSys AI
VSA
$8.85M
-112
Closed -$4.21M
LGF.B
1653
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-80,823
Closed -$2.59M
BECN
1654
DELISTED
Beacon Roofing Supply, Inc.
BECN
-38,858
Closed -$1.98M
ITCI
1655
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-84,358
Closed -$1.35M
SASR
1656
DELISTED
Sandy Spring Bancorp Inc
SASR
-50,822
Closed -$2.08M
SYRS
1657
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-1,725
Closed -$259K
LUMO
1658
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-43,070
Closed -$3.88M
TUP
1659
DELISTED
Tupperware Brands Corporation
TUP
-70,963
Closed -$4.4M
SLCA
1660
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-469,948
Closed -$14.6M
TAST
1661
DELISTED
Carrols Restaurant Group, Inc.
TAST
-11,514
Closed -$127K
MDC
1662
DELISTED
M.D.C. Holdings, Inc.
MDC
-12,616
Closed -$330K
AYX
1663
DELISTED
Alteryx Inc
AYX
-305,572
Closed -$6.11M
EXPR
1664
DELISTED
Express, Inc.
EXPR
-8,187
Closed -$1.15M
BFX
1665
DELISTED
BowFlex Inc.
BFX
-11,221
Closed -$191K
NSTG
1666
DELISTED
NanoString Technologies, Inc.
NSTG
-206,797
Closed -$3.31M
VRTV
1667
DELISTED
VERITIV CORPORATION
VRTV
-22,614
Closed -$746K
HT
1668
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-67,135
Closed -$1.28M
TWNK
1669
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-209,619
Closed -$2.93M
LTRPA
1670
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
-87,196
Closed -$1.05M
CIR
1671
DELISTED
CIRCOR International, Inc
CIR
-32,786
Closed -$1.77M
SYNH
1672
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-617,138
Closed -$32.1M
GLOP
1673
DELISTED
GASLOG PARTNERS LP
GLOP
-51,877
Closed -$1.19M
ACOR
1674
DELISTED
Acorda Therapeutics
ACOR
-627
Closed -$1.81M
BSMX
1675
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-557,430
Closed -$5.57M

Similar funds

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.49B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.